Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000145

Chairperson & CEO sold 9,500 shares at an average $494.79 ($4,700,505)

  • Chairperson & CEO acquired 9,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2026-09-18 Exercise or conversion : show line 1 in the form 10b5-1 +9,500 $117.76 $1,118,720 333,943 I
2026-09-18 Sale : show line 2 in the form 10b5-1 −248 $492.91 $122,241 333,695 I
2026-09-18 Sale : show line 3 in the form 10b5-1 −2,216 $493.78 $1,094,209 331,479 I
2026-09-18 Sale : show line 4 in the form 10b5-1 −4,269 $494.70 $2,111,871 327,210 I
2026-09-18 Sale : show line 5 in the form 10b5-1 −2,330 $495.66 $1,154,894 324,880 I
2026-09-18 Sale : show line 6 in the form 10b5-1 −277 $496.64 $137,569 324,603 I
2026-09-18 Sale : show line 7 in the form 10b5-1 −160 $498.25 $79,720 324,443 I
Open-market sales · 9,500 sh · avg $494.79 · $4,700,505

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-09-18 Exercise or conversion : show line 8 in the form 10b5-1 Stock Option −9,500 404,410 I
Loading xslF345X06/primarydocument.xml…